Moderna's COVID-19 vaccine sales remain strong, quarterly revenue exceeds expectations
Special Topic: Focus on US Stock Q4 2025 Earnings Reports
Moderna announced on Friday that, thanks to better-than-expected sales of its COVID-19 vaccine in the United States, the company's fourth-quarter revenue exceeded Wall Street expectations.
This Cambridge, Massachusetts-based company, which earned huge profits during the pandemic, has been under financial pressure due to a sharp decline in demand for its COVID-19 vaccine. The company is developing new products to fill the revenue gap and demonstrate the long-term viability of its mRNA technology.
The company reiterated its expectation of achieving 10% revenue growth in 2026.
According to data compiled by LSEG, the vaccine maker's quarterly revenue was $678 million, while analysts on average had expected $626.1 million.
Editor: Guo Mingyu
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
From Fitch Ratings to the Presidential Election, the "Political Bill" for the French Stock Market May Have Only Just Begun to Be Settled
The French stock market is about to face multiple political risks, and these uncertainties may further extend its weak performance compared to other European markets.
The main AI investment theme enters the second stage! "Turning Tokens into Cash Flow" drives allocation logic, Dynatrace (DT.US) stands at the forefront of a super trend
The valuation anchor for the AI investment boom is gradually shifting from "capital expenditure scale" to "capital return efficiency."
Awaiting Nvidia's earnings report, semiconductor sector leads gains in Asia-Pacific markets; South Korean stocks close up 0.97%, oil prices fall for the third straight day, bond market strengthens
The MSCI Asia-Pacific Index rose by 0.9%, with Samsung Electronics and SK Hynix contributing most to the gains. The Nikkei 225 closed up 0.6% at 66,262.16 points, while the Korea Composite Stock Price Index closed up 0.97% at 6,808.21 points. Brent crude fell by 1.7% to around $87 per barrel, with a cumulative decline of about 8% this week. Potential easing of inflationary pressures drove strength in the bond market.
FHToken Security Exploit Drains $20,000 From PancakeSwap V2 Pool
Crypto prices
More
